IgA nephropathy (IgAN) is an autoimmune disorder that affects the kidneys by impairing the filtration function of the small ...

Cross-species BBB-penetrant IV-delivered AAV gene therapy provides broad and robust CNS tau lowering in tauopathy mouse ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

Based in Basel, Granite Bio has emerged from stealth with a focus on developing first-in-class antibodies targeting multiple autoimmune diseases. The company has secured $100 million in two funding ...

The Middle East could be at the forefront of a global health revolution that dramatically improves society's chances of ...

The myasthenia gravis treatment market is anticipated to grow at a CAGR of 7.14% from US$1.973 billion in 2025 to US$2.785 ...

Granite Bio is ready to rock 'n' roll, unveiling with $100 million and hopes of shaping new antibody treatments targeting ...

Shruti Gupta, MD, MPH, and David Leaf, MD, MMSc, of the Renal Division, Department of Medicine at Brigham and Women’s Hospital are the first and senior authors, respectively, of a paper published in ...

Highly experienced in gene therapy dealmaking, Pettenaro will be driving Coave’s business development activities and ...

Treatment with a spinal cord stimulation system reduced pain and restored sensory nerve function in a small cohort of ...